DCF — ENCOMPASS HEALTH REHABILITATION OF G
Enterprise Value: $27.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$27.8M
Enterprise Value
$7.7M
PV of Cash Flows
$20.1M
PV of Terminal Value
$32.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $21.1M | $3.2M | 15.0% | $1.7M | $1.5M |
| Year 2 | $21.7M | $3.6M | 16.0% | $1.9M | $1.6M |
| Year 3 | $22.4M | $3.9M | 17.0% | $2.1M | $1.6M |
| Year 4 | $23.1M | $4.1M | 18.0% | $2.3M | $1.5M |
| Year 5 | $23.8M | $4.3M | 18.0% | $2.4M | $1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $27.8M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$20.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14852449114140234
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5